MALINVERNO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1343
EU - Europa 572
AS - Asia 90
SA - Sud America 1
Totale 2006
Nazione #
US - Stati Uniti d'America 1329
DE - Germania 151
IT - Italia 146
SE - Svezia 114
AT - Austria 69
CN - Cina 48
GB - Regno Unito 20
IE - Irlanda 20
MY - Malesia 16
CA - Canada 14
BE - Belgio 13
DK - Danimarca 11
UA - Ucraina 11
VN - Vietnam 9
FR - Francia 6
TR - Turchia 5
MM - Myanmar 4
NL - Olanda 4
FI - Finlandia 3
IN - India 3
KR - Corea 2
RU - Federazione Russa 2
BR - Brasile 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
PH - Filippine 1
RO - Romania 1
Totale 2006
Città #
Ann Arbor 496
Chandler 160
Frankfurt am Main 146
Fairfield 131
Wilmington 99
Woodbridge 82
Vienna 66
Seattle 62
Ashburn 51
Houston 46
Milan 45
Cambridge 42
Princeton 36
Dearborn 29
Dublin 20
Lawrence 18
Penang 16
Nanjing 13
Brussels 12
Altamura 11
Jacksonville 11
San Diego 10
Buffalo 6
Toronto 6
Fremont 5
Lissone 5
Appiano Gentile 4
Dong Ket 4
Kocaeli 4
Udine 4
Andover 3
Biassono 3
Edmonton 3
Falls Church 3
Hebei 3
Jinan 3
Kunming 3
London 3
Shenyang 3
Vigevano 3
Beijing 2
Bergamo 2
Boardman 2
Castelnuovo Scrivia 2
Changsha 2
Dalmine 2
Groningen 2
Guangzhou 2
Guiyang 2
Helsinki 2
Meda 2
Monza 2
Mumbai 2
Nanchang 2
Ningbo 2
Norwalk 2
Padova 2
Pavia 2
Sacramento 2
Tianjin 2
Wuhan 2
Arnsberg 1
Avigliana 1
Bologna 1
Bresso 1
Busto Arsizio 1
Chapel Hill 1
Chicago 1
Chuo 1
Collegeville 1
Crespino 1
Daejeon 1
Delhi 1
Florence 1
Gallarate 1
General Santos 1
Grumo Nevano 1
Haikou 1
Hangzhou 1
Hanover 1
Huntington Beach 1
Kiev 1
Lachine 1
Lafayette 1
Laurel 1
Los Angeles 1
Manchester 1
Messina 1
Misano Di Gera D'adda 1
Montréal 1
Ottawa 1
Port Townsend 1
Redmond 1
Rho 1
Rome 1
Saint Louis 1
Salerno 1
San Giuliano 1
Scandiano 1
Scottsdale 1
Totale 1751
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 362
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 267
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 164
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 159
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 153
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 142
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 135
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 131
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 117
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 116
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 101
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 61
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 56
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 48
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 39
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 37
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 34
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 25
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 23
Totale 2170
Categoria #
all - tutte 3584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201827 0000 00 04 32711
2018/2019147 10935 57 1218 12142428
2019/2020393 25331841 4540 4833 3932309
2020/2021612 121210237 3797 6166 43406045
2021/2022408 44455739 3127 1033 19172957
2022/2023552 601966370 7356 340 0000
Totale 2170